Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactamases and Class C β-Lactamases

The novel non-β-lactam β-lactamase inhibitor NXL104, in combination with cefepime, ceftazidime, ceftriaxone, amdinocillin, and meropenem, was tested against 190 extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolates, 94 AmpC-hyperproducing E. coli isolates...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lagacé-Wiens, P. R. S., Tailor, F., Simner, P., DeCorby, M., Karlowsky, J. A., Walkty, A., Hoban, D. J., Zhanel, G. G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3088241/
https://ncbi.nlm.nih.gov/pubmed/21357295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01722-10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados